Nektar Therapeutics (NKTR): R&D Expense
$117.33M
Year ended 2025-12-31
$131.77M
Trailing 12 months to 2026-06-30
-18.7%
3-year compound annual growth
-22.1%
5-year compound annual growth
-4.3%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $117.33M | -3.0% | 2026-03-13, From 2025-01-01 |
| 2024-12-31 | $120.91M | +5.9% | 2026-03-13, From 2024-01-01 |
| 2023-12-31 | $114.16M | -47.7% | 2025-03-14, From 2023-01-01 |
| 2022-12-31 | $218.32M | -45.5% | 2024-03-05, From 2022-01-01 |
| 2021-12-31 | $400.27M | -2.1% | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | $408.68M | -6.0% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $434.57M | +8.8% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $399.54M | +48.8% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $268.46M | +31.7% | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | $203.80M | +11.5% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $182.79M | +23.7% | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | $147.73M | -22.2% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $190.01M | +27.8% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $148.68M | +17.3% | 2015-02-26, From 2012-01-01 |
| 2011-12-31 | $126.77M | +17.3% | 2014-02-27, From 2011-01-01 |
| 2010-12-31 | $108.06M | +13.6% | 2013-03-01, From 2010-01-01 |
| 2009-12-31 | $95.11M | n/a | 2012-02-29, From 2009-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Nektar Therapeutics (NKTR) | 2025-12-31 | $117.33M | -3.0% |
| Agios Pharmaceuticals, Inc. (AGIO) | 2025-12-31 | $339.54M | +12.7% |
| Q32 Bio Inc. (QTTB) | 2025-12-31 | $19.16M | -60.2% |
| Aytu Biopharma, Inc (AYTU) | 2026-06-30 | $0 | -100.0% |
| Ocular Therapeutix, Inc (OCUL) | 2025-12-31 | $197.10M | +54.4% |
| Journey Medical Corp (DERM) | 2025-12-31 | $480.0K | -95.1% |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 2025-12-31 | $61.12M | -27.7% |
| Tango Therapeutics, Inc. (TNGX) | 2025-12-31 | $132.16M | -8.2% |
| Nuvation Bio Inc. (NUVB) | 2025-12-31 | $115.11M | +16.1% |
Compare NKTR, AGIO, QTTB, AYTU side by side · Screen every company in Pharmaceutical Preparations ↗